1.Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study
Seung Mi YEO ; Ji Young LIM ; Seok Won KIM ; Byung Joo CHAE ; Jonghan YU ; Jai Min RYU ; Ji Hye HWANG
Journal of Breast Cancer 2023;26(2):93-104
Purpose:
This study aimed to investigate the differences in sleep disturbance changes between patients receiving two hormone therapies (“tamoxifen plus ovarian function suppression group [T+OFS group]” versus “tamoxifen group [T group]”) and the chronological changes in sleep disturbances in each group.
Methods:
Premenopausal women with unilateral breast cancer who underwent surgery and were scheduled to receive hormone therapy (HT) with tamoxifen alone or with tamoxifen plus gonadotropin-releasing hormone (GnRH) agonist for ovarian function suppression were included. The enrolled patients wore an actigraphy watch for two weeks and completed questionnaires (insomnia, sleep quality, physical activity [PA], and quality of life [QOL]) at five time points: immediately before HT and 2, 5, 8, and 11 months after HT.
Results:
Among the 39 enrolled patients (21 and 18 patients in the T+OFS group and T group, respectively), 25 (17 and 8 patients in the T+OFS group and T group, respectively) were finally analyzed. There were no differences between the two groups in time-dependent changes in insomnia, sleep quality, total sleep time, rapid eye movement sleep rate, QOL, and PA;however, the severity of hot flashes was significantly higher in the T+OFS group than in the T group. Although the interaction between group and time was not significant, insomnia and sleep quality significantly worsened at 2–5 months of HT when changes over time were analyzed within the T+OFS group. In both the groups, PA and QOL were maintained without significant changes.
Conclusion
Unlike tamoxifen alone, tamoxifen plus GnRH agonist initially worsened insomnia and sleep quality, but gradually improved with long-term follow-up. Patients who initially experience insomnia during tamoxifen plus GnRH agonist administration can be reassured based on the results of this study, and active supportive care may be used during this period.
2.Increased CD68/TGFβ Co-expressing Microglia/Macrophages after Transient Middle Cerebral Artery Occlusion in Rhesus Monkeys
Hyeon Gu YEO ; Jung Joo HONG ; Youngjeon LEE ; Kyung Sik YI ; Chang Yeop JEON ; Junghyung PARK ; Jinyoung WON ; Jincheol SEO ; Yu Jin AHN ; Keonwoo KIM ; Seung Ho BAEK ; Eun Ha HWANG ; Green KIM ; Yeung Bae JIN ; Kang Jin JEONG ; Bon Sang KOO ; Philyong KANG ; Kyung Seob LIM ; Sun Uk KIM ; Jae Won HUH ; Young Hyun KIM ; Yeonghoon SON ; Ji Su KIM ; Chi Hoon CHOI ; Sang Hoon CHA ; Sang Rae LEE
Experimental Neurobiology 2019;28(4):458-473
The function of microglia/macrophages after ischemic stroke is poorly understood. This study examines the role of microglia/macrophages in the focal infarct area after transient middle cerebral artery occlusion (MCAO) in rhesus monkeys. We measured infarct volume and neurological function by magnetic resonance imaging (MRI) and non-human primate stroke scale (NHPSS), respectively, to assess temporal changes following MCAO. Activated phagocytic microglia/macrophages were examined by immunohistochemistry in post-mortem brains (n=6 MCAO, n=2 controls) at 3 and 24 hours (acute stage), 2 and 4 weeks (subacute stage), and 4, and 20 months (chronic stage) following MCAO. We found that the infarct volume progressively decreased between 1 and 4 weeks following MCAO, in parallel with the neurological recovery. Greater presence of cluster of differentiation 68 (CD68)-expressing microglia/macrophages was detected in the infarct lesion in the subacute and chronic stage, compared to the acute stage. Surprisingly, 98~99% of transforming growth factor beta (TGFβ) was found colocalized with CD68-expressing cells. CD68-expressing microglia/macrophages, rather than CD206⁺ cells, may exert anti-inflammatory effects by secreting TGFβ after the subacute stage of ischemic stroke. CD68⁺ microglia/macrophages can therefore be used as a potential therapeutic target.
Brain
;
Haplorhini
;
Immunohistochemistry
;
Infarction, Middle Cerebral Artery
;
Inflammation
;
Macaca mulatta
;
Magnetic Resonance Imaging
;
Microglia
;
Middle Cerebral Artery
;
Primates
;
Stroke
;
Transforming Growth Factor beta
3.Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Jae Hoon MOON ; Ji hoon KIM ; Eun Kyung LEE ; Kyu Eun LEE ; Sung Hye KONG ; Yeo Koon KIM ; Woo jin JUNG ; Chang Yoon LEE ; Roh Eul YOO ; Yul HWANGBO ; Young Shin SONG ; Min Joo KIM ; Sun Wook CHO ; Su jin KIM ; Eun Jae JUNG ; June Young CHOI ; Chang Hwan RYU ; You Jin LEE ; Jeong Hun HAH ; Yuh Seog JUNG ; Junsun RYU ; Yunji HWANG ; Sue K PARK ; Ho Kyung SUNG ; Ka Hee YI ; Do Joon PARK ; Young Joo PARK
Endocrinology and Metabolism 2018;33(2):278-286
BACKGROUND: The ongoing Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) aims to observe the natural course of papillary thyroid microcarcinoma (PTMC), develop a protocol for active surveillance (AS), and compare the long-term prognosis, quality of life, and medical costs between the AS and immediate surgery groups. METHODS: This multicenter prospective cohort study of PTMC started in June 2016. The inclusion criteria were suspicious of malignancy or malignancy based on fine needle aspiration or core needle biopsy, age of ≥18 years, and a maximum diameter of ≤1 cm. If there was no major organ involvement, no lymph node/distant metastasis, and no variants with poor prognosis, the patients were explained of the pros and cons of immediate surgery and AS before selecting AS or immediate surgery. Follow-up visits (physical examination, ultrasonography, thyroid function, and questionnaires) are scheduled every 6 months during the first 2 years, and then every 1 year thereafter. Progression was defined as a maximum diameter increase of ≥3, ≥2 mm in two dimensions, suspected organ involvement, or lymph node/distant metastasis. RESULTS: Among 439 enrolled patients, 290 patients (66.1%) chose AS and 149 patients (33.9%) chose immediate surgery. The median follow-up was 6.7 months (range, 0.2 to 11.9). The immediate surgery group had a larger maximum tumor diameter, compared to the AS group (7.1±1.9 mm vs. 6.6±2.0 mm, respectively; P=0.014). CONCLUSION: The results will be useful for developing an appropriate PTMC treatment policy based on its natural course and risk factors for progression.
Biopsy, Fine-Needle
;
Biopsy, Large-Core Needle
;
Cohort Studies*
;
Follow-Up Studies
;
Humans
;
Neoplasm Metastasis
;
Prognosis
;
Prospective Studies*
;
Quality of Life
;
Risk Factors
;
Thyroid Gland*
;
Thyroid Neoplasms
;
Ultrasonography
4.Corrigendum: Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
Jae Hoon MOON ; Ji Hoon KIM ; Eun Kyung LEE ; Kyu Eun LEE ; Sung Hye KONG ; Yeo Koon KIM ; Woo Jin JEONG ; Chang Yoon LEE ; Roh Eul YOO ; Yul HWANGBO ; Young Shin SONG ; Min Joo KIM ; Sun Wook CHO ; Su Jin KIM ; Eun Jae CHUNG ; June Young CHOI ; Chang Hwan RYU ; You Jin LEE ; Jeong Hun HAH ; Yuh Seog JUNG ; Junsun RYU ; Yunji HWANG ; Sue K PARK ; Ho Kyung SUNG ; Ka Hee YI ; Do Joon PARK ; Young Joo PARK
Endocrinology and Metabolism 2018;33(3):427-427
No abstract available.
5.Effects of the C3G/D3G anthocyanins-rich black soybean testa extracts on improvement of lipid profiles in STZ-induced diabetic rats.
So Young PARK ; Sujeong PAK ; Song Joo KANG ; Na Young KIM ; Da Saem KIM ; Min Jin KIM ; Seon Ah KIM ; Ji Young KIM ; So Yeon PARK ; So Hyun PARK ; Cho Rong YOUN ; Bo Ram LEE ; Hyo Eun LEE ; So Young CHOI ; Hee Won CHOI ; Jin Yeo HEO ; A Yeong HWANG ; Myoung Sook LEE
Journal of Nutrition and Health 2015;48(4):299-309
PURPOSE: The purpose of this study was to examine the effect of black soybean (CJ-3) testa extracts on lipid profiles in streptozotocin (STZ)-induced diabetic rats. METHODS: One control group and four STZ-induced diabetic groups with different doses of black soybean (CJ-3) testa extracts treatment [0 mg/kg (diabetic control, EX), 250 mg/kg (EX-250), 500 mg/kg (EX-500), 1,000 mg/kg (EX-1000)] were orally administered for 4 weeks. RESULTS: All CJ-3 treatment groups had remarkably lower serum triglyceride (TG) levels than that of EX group (p < 0.05) whereas hepatic TG contents did not show any differences. Results from serum total cholesterol (TC) concentrations of EX-250 and EX-1000 groups were decreased compared to EX group (p < 0.05). Furthermore, protein levels of 3-hydroxy-3-methyl-glutaryl-Coenzyme A (HMG-CoA) reductase from the liver decreased in all treatment groups (p < 0.05). However, significant differences were not observed in serum glucose and insulin, and glucose transporter 4 (GLUT-4) protein expression in skeletal muscle tissue. CONCLUSION: These results suggest that black soybean testa extracts could be useful for improvement of hyperlipidemia and hypercholesteremia in diabetes.
Animals
;
Anthocyanins
;
Blood Glucose
;
Cholesterol
;
Glucose Transport Proteins, Facilitative
;
Hypercholesterolemia
;
Hyperlipidemias
;
Insulin
;
Liver
;
Muscle, Skeletal
;
Oxidoreductases
;
Rats*
;
Soybeans*
;
Streptozocin
;
Triglycerides
6.Antigenic properties and virulence of foot-and-mouth disease virus rescued from full-length cDNA clone of serotype O, typical vaccine strain.
Rae Hyung KIM ; Jia Qi CHU ; Jeong Nam PARK ; Seo Yong LEE ; Yeo Joo LEE ; Mi Kyeong KO ; Ji Hyeon HWANG ; Kwang Nyeong LEE ; Su Mi KIM ; Dongseob TARK ; Young Joon KO ; Hyang Sim LEE ; Min Goo SEO ; Min Eun PARK ; Byounghan KIM ; Jong Hyeon PARK
Clinical and Experimental Vaccine Research 2015;4(1):114-118
We cloned the full-length cDNA of O Manisa, the virus for vaccinating against foot-and-mouth disease. The antigenic properties of the virus recovered from the cDNA were similar to those of the parental virus. Pathogenesis did not appear in the pigs, dairy goats or suckling mice, but neutralizing antibodies were raised 5-6 days after the virus challenge. The utilization of O Manisa as a safe vaccine strain will increase if recombinant viruses can be manipulated by inserting or removing a marker gene for differential serology or replacing the protective gene from another serotype.
Animals
;
Antibodies, Neutralizing
;
Clone Cells*
;
Cloning, Molecular
;
DNA, Complementary*
;
Foot-and-Mouth Disease
;
Foot-and-Mouth Disease Virus*
;
Goats
;
Humans
;
Mice
;
Parents
;
Swine
;
Virulence*
7.Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines.
Soo Mee BANG ; Moon Ju JANG ; Kyoung Ha KIM ; Ho Young YHIM ; Yeo Kyeoung KIM ; Seung Hyun NAM ; Hun Gyu HWANG ; Sung Hwa BAE ; Sung Hyun KIM ; Yeung Chul MUN ; Yang Ki KIM ; Inho KIM ; Won Il CHOI ; Chul Won JUNG ; Nan Hee PARK ; Nam Kyong CHOI ; Byung Joo PARK ; Doyeun OH
Journal of Korean Medical Science 2014;29(2):164-171
In 2010, we proposed the first Korean Guidelines for the Prevention of Venous Thromboembolism (VTE). It was applicable to Korean patients, by modifying the contents of the second edition of the Japanese guidelines for the prevention of VTE and the 8th edition of the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines. From 2007 to 2011, we conducted a nationwide study regarding the incidence of VTE after major surgery using the Health Insurance Review and Assessment Service (HIRA) database. In addition, we have considered the 9th edition of the ACCP Evidenced-Based Clinical Practice Guidelines, published in 2012. It emphasized the importance of clinically relevant events as opposed to asymptomatic outcomes with preferences for both thrombotic and bleeding outcomes. Thus, in the development of the new Korean guidelines, three major points were addressed: 1) the new guidelines stratify patients into 4 risk groups (very low, low, moderate, and high) according to the actual incidence of symptomatic VTE from the HIRA databases; 2) the recommended optimal VTE prophylaxis for each group was modified according to condition-specific thrombotic and bleeding risks; 3) guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and/or physician advice.
Age Factors
;
Anticoagulants/adverse effects/*therapeutic use
;
Asian Continental Ancestry Group
;
Evidence-Based Medicine
;
Heparin, Low-Molecular-Weight/therapeutic use
;
Humans
;
*Mechanical Thrombolysis
;
Neoplasms/complications/surgery
;
Republic of Korea
;
Risk Assessment
;
Surgical Procedures, Operative/adverse effects
;
Venous Thromboembolism/etiology/prevention & control/*therapy
8.Novel Balance Tests for Assessing Functional Ankle Instability: Relationships with BMI and Gender.
Harshad P PATANKAR ; Eui Dong YEO ; Seung Joo KIM ; Hong Chul LIM ; Myong Hoi HWANG ; Sehyun PARK ; Hak Jun KIM
Journal of Korean Foot and Ankle Society 2012;16(2):128-134
PURPOSE: To design novel balance tests to assess FAI and evaluate whether these tests are affected by BMI or gender, with the goal of developing reliable FAI assessment tests that are not influenced by these factors. MATERIALS AND METHODS: Participants included 20 young, healthy volunteers, 12 males and 8 females, with a mean age of 24+/-4 years and a mean BMI of 23+/-2.28. None of the subjects had known ankle instability. The following tests were assessed in each participant: single leg balance (SLB), percentage of leg press (PLP), single leg cycling (SLC), one leg squat (OLS), multiple direction reach-front/back/side (MDR-F/B/S), single leg hop (SLH), two leg jump (TLJ) and side step (SS). Data were analyzed using the SPSS 12.0 software program with ANOVA and t-test used. RESULTS: When grouped by BMI, we found that despite differences in BMI, the performances of all subjects were equivalent except for the one-leg-squat test, for which the mean ratios for underweight (1.69+/-0), normal weight (1.05+/-0.19), and overweight (0.93+/-0.30) individuals were significantly different (p=0.02); ratios for SLB (p=0.273), SLC (p=0.903), PLP (p=0.664), MDR-F/B/S (p=0.498, 0.908, and 0.503, respectively), SLH (p=0.332) were not significantly different. When calculated according to gender, we found that the OLS (p=0.013) and MDRS (p=0.034) were significantly different, while parameters for all the remaining tests were not affected. CONCLUSION: We found that the SLB, PLP, SLC, MDR-F/B, and SLH ratios were unaffected by BMI or sex and, therefore, are reliable parameters for assessing ankle instability.
Animals
;
Ankle
;
Female
;
Humans
;
Humulus
;
Leg
;
Male
;
Overweight
;
Thinness
9.Comparison between Conventional 4 L Polyethylene Glycol and Combination of 2 L Polyethylene Glycol and Sodium Phosphate Solution as Colonoscopy Preparation.
Jung Won LEE ; Nayoung KIM ; Byung Hyo CHA ; Byoung Hwan LEE ; Tae Jun HWANG ; Yu Jeong JEONG ; Tae Hyuck CHOI ; Hee Sup KIM ; Hyung Joon MYUNG ; Jangeon KIM ; Je Hyuck JANG ; Yeo Myeong KIM ; Jong Yeop KIM ; Sang Wook PARK ; Hyun Kyung PARK ; Seungchul SUH ; Pyoung Ju SEO ; Joon Chang SONG ; Cheol Min SHIN ; Young Ook EUM ; Jung Hee KWON ; Jin Joo KIM ; Byeong Jun SONG ; Young Soo PARK ; Dong Ho LEE
The Korean Journal of Gastroenterology 2010;56(5):299-306
BACKGROUND/AIMS: Effective bowel preparation is essential for accurate diagnosis of colon disease. We investigated efficacy and safety of 2 L polyethylene glycol (PEG) solution with 90 mL sodium phosphate (NaP) solution compared with 4 L PEG method. METHODS: Between August 2009 and April 2010, 526 patients were enrolled who visited Seoul National University Bundang Hospital for colonoscopy. We allocated 249 patients to PEG 4 L group and 277 patients to PEG 2 L with NaP 90 mL group. Detailed questionnaires were performed to investigate compliance, satisfaction and preference of each method. Bowel preparation quality and segmental quality were evaluated. Success was defined as cecal intubation time less than 20 minutes without any help of supervisors. RESULTS: Both groups revealed almost the same baseline characteristics except the experience of operation. PEG 4 L group's compliance was lower than PEG 2 L with NaP 90 mL group. Success rate and cecal intubation time was not different between two groups. Overall bowel preparation quality of PEG 2 L with NaP 90 mL group was better than PEG 4 L group. Segmental bowel preparation quality of PEG 2 L with NaP 90 mL group was also better than PEG 4 L group in all segments, especially right side colon. Occurrence of hyperphosphatemia was higher in PEG 2 L with NaP 90 mL group than PEG 4 L group. However, significant adverse event was not reported. CONCLUSIONS: PEG 2 L with NaP 90 mL method seems to be more effective bowel preparation than PEG 4 L method.
Administration, Oral
;
Adult
;
Aged
;
Colonic Diseases/diagnosis
;
Colonoscopy/*methods
;
Humans
;
Male
;
Middle Aged
;
Patient Compliance
;
Phosphates/*administration & dosage
;
Polyethylene Glycols/*administration & dosage
;
Questionnaires
;
Solutions
;
Therapeutic Irrigation
10.Effectiveness of Sodium Fluoride as a Glycolysis Inhibitor on Blood Glucose Measurement: Comparison of Blood Glucose using Specimens from the Korea National Health and Nutrition Examination Survey.
Yong Wha LEE ; Young Joo CHA ; Seok Lae CHAE ; Junghan SONG ; Yeo Min YUN ; Hae Il PARK ; Moon Woo SEONG ; Dong Hee WHANG ; Hyun Soo KIM ; Jeong Ho KIM ; Bong Suk LEE ; Yoo Sung HWANG
The Korean Journal of Laboratory Medicine 2009;29(6):524-528
BACKGROUND: Accurate measurement of blood glucose concentrations is essential for defining diabetes, and the minimization of ex vivo glycolysis has been recommended. Recent guidelines advocate two kinds of methods for sample collection and processing: either the sodium fluoride (NaF) method or immediate refrigeration using a serum separation tube (SST). We investigated the difference between the two methods in measuring subsequent glucose concentrations using blood specimens from participants recruited for the fourth Korean National Health and Nutrition Examination Survey. METHODS: Paired venous blood samples were collected in an SST and a NaF tube from 1,103 men and women. SST serum was separated within 30 min, including standing for 15 min, and then refrigerated. The NaF samples were refrigerated, but not separated until immediately before analysis. We compared the blood glucose concentrations between the SST (SST glucose) and NaF (NaF glucose) methods. RESULTS: The mean SST glucose was significantly higher than NaF glucose (99.0 mg/dL vs 96.5 mg/dL, P<0.05). NaF glucose showed a negative mean bias of 2.6 mg/dL vs SST glucose but showed high correlation (R=0.9899). There was no significant correlation between the bias of blood glucose concentrations by two methods and the storage time of NaF glucose. CONCLUSIONS: The negative bias associated with the use of NaF tubes may significantly affect the prevalence of diabetes. Serum separation and refrigeration within 30 min after venous sampling is recommended over NaF method, not only to minimize the preanalytical impact on detecting diabetes but also to reduce sample volume and number of tubes.
Blood Glucose/*analysis
;
Blood Specimen Collection/*methods
;
Diabetes Mellitus/diagnosis
;
Female
;
Glycolysis/*drug effects
;
Humans
;
Male
;
Nutrition Surveys
;
Republic of Korea
;
Sodium Fluoride/*pharmacology
;
Specimen Handling

Result Analysis
Print
Save
E-mail